Persian Gulf Syndrome Clinical Trial
Official title:
Acupuncture in the Treatment of Gulf War Illness
This unblinded Phase II clinical trial tested the effects of individualized acupuncture treatments offered in extant acupuncture practices in the community; practitioners had at least 5 years of experience plus additional training provided by the study. Veterans with diagnosed symptoms of Gulf War Illness were randomized to either six months of biweekly acupuncture treatments (group 1, n=52) or 2 months of waitlist followed by weekly acupuncture treatments (group 2, n=52). Measurements were taken at baseline, 2, 4 and 6 months. The primary outcome is the SF-36 physical component scale score (SF-36P).
Gulf War Illness (GWI) is a complex, poorly understood illness characterized by many
symptoms, including fatigue after exertion, sleep and mood problems, difficulty
concentrating, difficulty thinking and finding words, and musculoskeletal pain. Individuals
often present with many symptoms, some of them severe and disabling, and with additional
medical diagnoses, including chronic fatigue syndrome, fibromyalgia, irritable bowel
syndrome, digestive complaints, and mood-related psychiatric disorders, such as depression,
posttraumatic stress disorder, and other anxiety disorders. More than 100,000 veterans of
the first Gulf War (Operation Desert Shield/Storm, 1990-1991) out of 700,000 US service
personnel deployed to the Persian Gulf have presented with medical complaints through
programs established to address the problem, which came to be called chronic multisymptom
illness (CMI). Groups of veterans in the United Kingdom, Canada, and Australia have been
identified with similar problems. The veterans have received treatment directed at their
symptoms, but at 5- and 10-year follow-ups, many reported their symptoms remained, some of
them severe and disabling. Clearly, an effective treatment for these conditions would be of
great benefit to those who were injured during their military service.
The cause of CMI is unknown, and the symptoms can not be explained by physical and
laboratory examinations. Several factors have been considered, including exposure to
vaccines, chemicals likely to be encountered in combat (chemical weapons, smoke, pesticides)
and stress related to military service, deployment, and combat. After investigation by the
Centers for Disease Control (CDC), researchers suspect that the symptoms reflect a range of
injuries to the nervous system. It may be that the factors that led to these injuries were
not specific to the Persian Gulf region, and that veterans of the current war in Iraq and
Afghanistan, as well as active duty personnel, are exposed to similar stressors and will
benefit from an investigation of CMI and its treatment.
The goal of this study is to help identify whether acupuncture is an effective treatment for
Gulf War Syndrome. Acupuncture is likely to be helpful in treating GWI because it has
already been used successfully to reduce many of its key symptoms - fatigue, irritability,
anxiety, insomnia, and pain. Acupuncture treatment is designed to treat each individual's
symptoms making it very well suited for treating the varied symptoms of GWI. Veterans will
receive care that is directed specifically at their most distressing symptom. Although the
specific etiology of CMI is unknown, acupuncture's analgesic and anti-inflammatory effects
are likely to be helpful. Acupuncture seems to work, in part, on peripheral nerves near the
site of injury, in the brain, central nervous system, and on the endocrine system, in ways
that promote the body's own efforts to reduce pain and heal even chronic injuries. Numerous
studies have shown acupuncture is well tolerated by patients, safe, and cost-effective
compared to routine care. Acupuncture will be provided by licensed acupuncturists with at
least 5 years of clinical experience, who have received 20-hours of training related to
symptoms of GWI.
Subjects were recruited via local advertisements and direct mailing to veterans on the
Defense Manpower Data Center (http://www.virec.research.va.gov/Non-VADataSources/DMDC.htm).
Through questionnaires, physician assessment, and medical histories, the investigators
measured the severity of symptoms before beginning treatment, and after 2, 4 and 6 months of
treatment. One group of patients received acupuncture evaluation and treatment twice per
week for 6 months. A second group, for comparison purposes, will be monitored on a wait list
for 2 months, and will then be offered weekly acupuncture for 4 months. Based on previous
acupuncture research on fatigue, stress, and pain, the investigators expect this length of
treatment will be enough for patients to receive significant benefit. The investigators also
planed to collect samples of blood from our volunteers that will help identify possible
disease mechanisms for the illness and track the effects of treatment.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02075489 -
Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans
|
N/A | |
Completed |
NCT01437891 -
Sentra AM® and Sentra PM® for Post-traumatic Stress Disorder (PTSD) and Gulf War Fibromyalgia (GWF)
|
N/A | |
Recruiting |
NCT04255498 -
Understanding GWI: Integrative Modeling
|
Phase 1 | |
Completed |
NCT01700725 -
Gulf War Illness Nasal Irrigation Study
|
Phase 2 | |
Completed |
NCT01267045 -
Mindfulness-Based Stress Reduction for Gulf War Syndrome
|
N/A | |
Completed |
NCT00007514 -
Investigate Olfactory Functioning as a Possible Proxy for Neurotoxic Exposure in Cohorts of Deployed and Non-Deployed Gulf War-Era Veterans.
|
N/A | |
Completed |
NCT00007748 -
Exercise and Behavioral Therapy Trial (EBT).
|
Phase 3 | |
Completed |
NCT00568555 -
Effects of Low Dose Naltrexone in Fibromyalgia
|
N/A | |
Completed |
NCT01291758 -
Exercise in Gulf War Illness (GWI)
|
||
Completed |
NCT00007735 -
Antibiotic Treatment of Gulf War Veterans' Illnesses
|
Phase 3 | |
Completed |
NCT00810368 -
Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)
|
Phase 2 | |
Completed |
NCT02804828 -
Mitochondrial Cocktail for Gulf War Illness
|
N/A |